曾 珍,杜 驰,涂 梨.活性乳清蛋白对乳腺癌荷瘤小鼠化疗期间营养状态的影响[J].中国肿瘤,2019,28(6):476-482.
活性乳清蛋白对乳腺癌荷瘤小鼠化疗期间营养状态的影响
Effects of Active Whey Protein on Nutritional and Immune Status of Mice Bearing Triple-negative Breast Cancer with Chemotherapy
投稿时间:2018-12-26  
DOI:10.11735/j.issn.1004-0242.2019.06.A014
中文关键词:  活性乳清蛋白  乳腺肿瘤  营养治疗
英文关键词:whey protein  breast neoplasms  nutritional therapy
基金项目:四川省医学会青年创新课题(Q16042)
作者单位
曾 珍 四川大学华西医院生物治疗国家重点实验室 
杜 驰 内江市第二人民医院 
涂 梨 四川大学华西医院生物治疗国家重点实验室 
摘要点击次数: 1770
全文下载次数: 323
中文摘要:
      摘 要:[目的] 探究活性乳清蛋白对化疗期间荷瘤小鼠的营养状态、免疫调节和疗效的影响。[方法] 建立三阴乳腺癌小鼠皮下移植瘤模型,根据干预措施不同随机分为4组,分别为空白对照组(Control组)、紫杉醇化疗组(Control+紫杉醇组)、添加酪蛋白的紫杉醇化疗组(酪蛋白+紫杉醇组)、添加活性乳清蛋白的紫杉醇化疗组(活性乳清蛋白+紫杉醇组)。观察和测量小鼠体重、肿瘤体积、肿瘤重量的变化情况,比较各组小鼠的生存期,检测各组小鼠血液及肿瘤组织中谷胱甘肽(glutathione,GSH)含量。[结果] 活性乳清蛋白+紫杉醇组瘤鼠体重下降速度明显缓于酪蛋白+紫杉醇组和Control+紫杉醇组,试验进行第31d 活性乳清蛋白+紫杉醇组瘤鼠体重[(20.52±1.10)g],显著高于酪蛋白+紫杉醇组[(19.03±1.76)g]和Control+紫杉醇组[(18.71±0.86)g],差异具有统计学意义。活性乳清蛋白+紫杉醇组瘤鼠肿瘤体积变化与其他各组差异不具有统计学意义。活性乳清蛋白+紫杉醇组生存期较Control+紫杉醇组与酪蛋白+紫杉醇组生存期明显延长。活性乳清蛋白+紫杉醇组肿瘤组织中GSH含量[(34.5±18.0)μmol/L]低于酪蛋白+紫杉醇组[(55.3±23.8)μmol/L]和Control+紫杉醇组[(54.9±11.7)μmol/L]。而血液中,活性乳清蛋白+紫杉醇组血液的GSH含量[(19.1±0.7)μmol/L]高于酪蛋白+紫杉醇组[(13.0±8.8)μmol/L]和Control+紫杉醇组[(15.2±9.7)μmol/L]。但无论是肿瘤组织中还是血液中,各处理组间GSH含量差异均无统计学意义(P>0.05)。[结论]活性乳清蛋白联合化疗减缓小鼠体重下降,改善营养状态,抑制肿瘤增长,延长荷瘤小鼠生存期,改善预后。
英文摘要:
      Abstract:[Purpose] To investigate the effect of active whey protein(ABD) on nutritional and immune status of mice bearing triple-negative breast cancer(TNBC) undergoing chemotherapy. [Methods] The triple-negative breast cancer 4T1 cells were inoculated in BALB/c mice. The tumor bearing mice were randomly divided into 4 groups with 6 mice in each group:control group,paclitaxel group,casein + paclitaxel group and ABD+ paclitaxel group. The weight of mice,volume of tumor were observed and measured. The overall survival of mice and glutathione(GSH) levels in blood and tumors were analyzed. [Results] Weight of mice in ABD+ paclitaxel group[(20.52±1.10)g] was significantly higher than those of casein + paclitaxel group[(19.03±1.76)g] and paclitaxel group[(18.71±0.86)g](P<0.05) on d31. The tumor sizes in ABD+ paclitaxel group was lower than that in other groups(P<0.05). The overall survival of the ABD+ paclitaxel group was significantly longer than paclitaxel group and casein + paclitaxel group. The GSH levels in tumor tissue of ABD+ paclitaxel group,casein + paclitaxel and paclitaxel group were (34.5±18.0)μmol/L,(55.3±23.8)μmol/L and (54.9±11.7)μmol/L,respectively. However,GSH levels in blood of three groups were (19.1±0.7)μmol/L,(13.0±8.8)μmol/L and (15.2±9.7)μmol/L,respectively. There was no significant difference in GSH contents both in blood and tumor tissue among three groups(P>0.05). [Conclusion] Whey protein combined with chemotherapy can attenuate weight loss,improve nutritional status,inhibit tumor growth and prolong survival time in mice bearing triple negative breast cancer.
在线阅读   查看全文  查看/发表评论  下载PDF阅读器